๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma

โœ Scribed by Jean-Philippe Spano, Y. Vano, S. Vignot, T. De La Motte Rouge, L. Hassani, R. Mouawad, F. Menegaux, D. Khayat, L. Leenhardt

Book ID
118821463
Publisher
Springer US
Year
2011
Tongue
English
Weight
245 KB
Volume
29
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Thyroglobulin may be undetectable in the
Thyroglobulin may be undetectable in the serum of patients with metastatic disease secondary to differentiated thyroid carcinoma. Follow-up of differentiated thyroid carcinoma
โœ Simon Grant; Brian Luttrell; Thomas Reeve; Josephine Wiseman; Errol Wilmshurst; ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 485 KB ๐Ÿ‘ 2 views

To assess the value of serum thyroglobulin (Tg) levels in the follow-up of differentiated thyroid carcinoma after ablative therapy simultaneous Tg estimations and radioiodine (I3'I) scans were performed on patients during an 18-month follow-up period. In this study, 287 scans were performed on 200 p